Ignite Creation Date:
2025-12-18 @ 8:12 AM
Ignite Modification Date:
2025-12-18 @ 8:12 AM
Study NCT ID:
NCT07103824
Status:
None
Last Update Posted:
2025-08-05 00:00:00
First Post:
2025-07-29 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Validity and Test-Retest Reliability of Reactive Neurocognitive Upper Extremity Tests in Archers
Sponsor:
None
Organization:
Study Overview
Official Title:
Validity and Test-Retest Reliability of Reactive Neurocognitive Upper Extremity Tests in Archers
Status:
None
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In archery, the evaluation of reaction time and neurocognitive functions plays a critical role in the management of upper extremity (UE) injuries and return-to-play (RTP) processes. Reaction time reflects an athlete's ability to respond quickly and effectively to visual stimuli, which is particularly crucial in precision-based sports like archery that require high levels of coordination and attention.
With advancements in technology, LED-based systems such as BlazePod™, Catchpad, and ReactionX are increasingly being used in clinical and sports settings to assess cognitive performance and motor responses simultaneously. These tools offer dynamic and motivating methods for evaluating neurocognitive functions. However, before such devices can be reliably used in clinical or research environments, their validity and test-retest reliability must be systematically examined.
The aim of this study is to evaluate the test-retest reliability and validity of Reactive Neurocognitive Upper Extremity Tests-specifically the Reactive Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Reactive 90/90 Wall Throws Test-using the Catchpad system in archers. Based on methodological standards for reliability studies, a minimum of 18 participants will be included. Each participant will attend three test sessions over three weeks: Catchpad in weeks one and three, and BlazePod™ in week two. To ensure blinding, different researchers will conduct the assessments, record the data, and perform the statistical analyses.
Findings from this study are expected to provide scientific evidence supporting the use of Catchpad technology in neurocognitive and reaction time assessments, contributing to more objective decision-making during RTP and potentially reducing the risk of reinjury.
With advancements in technology, LED-based systems such as BlazePod™, Catchpad, and ReactionX are increasingly being used in clinical and sports settings to assess cognitive performance and motor responses simultaneously. These tools offer dynamic and motivating methods for evaluating neurocognitive functions. However, before such devices can be reliably used in clinical or research environments, their validity and test-retest reliability must be systematically examined.
The aim of this study is to evaluate the test-retest reliability and validity of Reactive Neurocognitive Upper Extremity Tests-specifically the Reactive Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Reactive 90/90 Wall Throws Test-using the Catchpad system in archers. Based on methodological standards for reliability studies, a minimum of 18 participants will be included. Each participant will attend three test sessions over three weeks: Catchpad in weeks one and three, and BlazePod™ in week two. To ensure blinding, different researchers will conduct the assessments, record the data, and perform the statistical analyses.
Findings from this study are expected to provide scientific evidence supporting the use of Catchpad technology in neurocognitive and reaction time assessments, contributing to more objective decision-making during RTP and potentially reducing the risk of reinjury.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: